11 research outputs found

    Seismic reflections from the crystalline crust below the Continental Deep Drilling Site KTB-modeling and inference on reflector properties

    Get PDF
    The three-dimensional (3-D) reflection-seismic data set ISO-89 3D was recorded near the deep borehole KTB in southeastern Germany. Reflections from the SE1 reflector and from the top of the Erbendorf body (EB) in the upper crystalline crust can be identified in 5–10% of the single-shot sections. The reflectors have been first identified in previous studies of stacked and migrated seismic data. In this paper the velocity and density variations of these two structures are estimated in a new way using true amplitude single-shot (vibroseis) data. The method uses the direct wave Pg as a reference phase and models the amplitude ratios of the SE1 and EB reflections to Pg. Modeling in this paper uses a combination of ray theory and the reflectivity method, and the SE1 and the top of the EB are assumed to be obliquely oriented 1-D structures. Pg modeling shows that a depth-dependent velocity function within the uppermost crystalline basement explains the amplitudes and travel times of this phase with sufficient accuracy. The largest observed amplitude ratios SE1/Pg and EB/Pg are explained by laminated models with strong velocity contrasts and with reflection coefficients of magnitude 0.1–0.2 (SE1) and 0.05–0.15 (EB). The total thickness of the reflecting zones is less than ∼300 m. Pg amplitude modeling requires low Qp factors (<100) to a depth of ∼1 km, whereas at larger depths, values of several hundred are necessary to keep the SE1 and EB velocity contrasts in realistic ranges. Both reflectors can be interpreted as cataclastic zones. For the SE1 this interpretation agrees with the view that it is a steeply dipping thrust fault which continues the tectonic Franconian Lineament into the upper crust. We assume that the EB is the fractured top of a high-velocity zone at depths below ∼10 km, known from earlier wide-angle measurements. Both reflectors have large weakly reflecting or nonreflecting parts. The SE1 is nonreflecting at the intersection with the KTB borehole

    Seismic studies around the Kola Superdeep Borehole, Russia

    No full text
    The Kola Superdeep Borehole (SG-3) provided an ideal opportunity to test hypotheses on the origins of crustal reflections and on the presence and seismic expression of fluids in the upper crust. The alternative sources of crustal reflections include compositional changes, shear zones, fluids, and metamorphic facies changes, all of which are represented at the well. Both the 38-km-long CDP section and the borehole VSPs in the range 2.2–6.0 km demonstrate the presence of reflections from dipping compositional layering, shear zones, and fluid-filled zones. Subhorizontal reflectivity zones are interpreted as horizontal fluid-filled fracture-type reservoir rocks. Results suggest the presence of fluids down to a depth of at least 12 km in the upper crust; the presence of these fluids lowering seismic velocity causes estimates of upper crustal composition to be too felsic

    ΠžΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΡ Ρ€Π°Π±ΠΎΡ‡ΠΈΡ… процСссов ΠΏΠΎ Ρ€Π΅ΠΊΡ€ΡƒΡ‚ΠΈΠ½Π³Ρƒ Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ² ΠΈ Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠ΅ рСконвалСсцСнтной ΠΏΠ»Π°Π·ΠΌΡ‹ Π² ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΠΈ COVID-19

    No full text
    Background. The pandemic of the new coronavirus infection has challenged the medical community for quickly finding and implementing effective methods of treatment. In the absence of a vaccine or specific therapy with proven effectiveness, the usage of convalescent plasma can be the one of perspective methods. An important aspect of this technology is the efficient and safe preparation of convalescent plasma. To date, in the world literature there are practically no publications about donor recruitment and the specifics of the preparation of convalescent plasma. Purpose of the research. Presentation of the experience of organizing a workflow for recruiting donors and stockpiling of convalescent plasma with a high titer of virus-neutralizing antibodies to SARS-CoV-2. Methods. The analysis of the work of the Blood Service of the Moscow Department of Health for stockpiling of COVID-19 convalescent plasma has been executed. In total it has been stockpiled 1240 doses. The normative documentation has been developed by a working group on the basis of the current federal legislation of Russian federation and been approved by the Moscow Department of Health. The titer of neutralizing antibodies (VNA) has been determined as the basic method for assessing the immunological viability of convalescent plasma. The main characteristics of donors, the characteristics of the disease course, the results of preliminary testing for the presence of specific antibodies by ELISA and CLIA methods has been compared with VNA titers in the stockpiled convalescent plasma. Results. Due to a Moscow Health Departments order No. 325 dated 01.04.2020 (a basic local regulatory document) it has been developed a regulation for the stockpiling, examination, storage, safety and transfering of fresh frozen pathogen-reduced plasma of COVID-19 convalescent donors to medical organizations of the Moscow Health Department. For arranging an interaction with donors it has been created a call-center. For effective preliminary selection, it has been formed a donor characteristics list, which has been combined with screening of specific antibodies by ELISA and CLIA methods. Conclusions. Developed a system of recruiting donors and procurement process of convalescent plasma for treatment Π‘OVID-19, which includes the necessary regulations, algorithms for the selection and recruitment of donors, the registry of donors and recipients, algorithms, efficiency and safety of convalescent plasma.ОбоснованиС. ПандСмия Π½ΠΎΠ²ΠΎΠΉ коронавирусной ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ поставила ΠΏΠ΅Ρ€Π΅Π΄ мСдицинским сообщСством Π·Π°Π΄Π°Ρ‡Ρƒ быстрого поиска ΠΈ внСдрСния эффСктивных ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊ лСчСния. Π’ условиях отсутствия Π²Π°ΠΊΡ†ΠΈΠ½Ρ‹ ΠΈ срСдств спСцифичСской Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ с Π΄ΠΎΠΊΠ°Π·Π°Π½Π½ΠΎΠΉ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒΡŽ Π² качСствС ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· пСрспСктивных ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊ рассматриваСтся трансфузия рСконвалСсцСнтной ΠΏΠ»Π°Π·ΠΌΡ‹ (РП). Π’Π°ΠΆΠ½Ρ‹ΠΌ аспСктом Π΄Π°Π½Π½ΠΎΠΉ Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ являСтся Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠ° эффСктивного ΠΈ бСзопасного ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π°. На сСгодняшний дСнь ΠΏΡƒΠ±Π»ΠΈΠΊΠ°Ρ†ΠΈΠΈ ΠΏΠΎ Ρ€Π΅ΠΊΡ€ΡƒΡ‚ΠΈΠ½Π³Ρƒ Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ² ΠΈ особСнностях Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ РП Π² ΠΌΠΈΡ€ΠΎΠ²ΠΎΠΉ Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π΅ практичСски ΠΎΡ‚ΡΡƒΡ‚ΡΡ‚Π²ΡƒΡŽΡ‚. ЦСль исслСдования Анализ ΠΎΠΏΡ‹Ρ‚Π° ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ Ρ€Π°Π±ΠΎΡ‡Π΅Π³ΠΎ процСсса ΠΏΠΎ ΠΏΡ€ΠΈΠ²Π»Π΅Ρ‡Π΅Π½ΠΈΡŽ Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ² ΠΈ Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠ΅ РП с высоким Ρ‚ΠΈΡ‚Ρ€ΠΎΠΌ Π²ΠΈΡ€ΡƒΡΠ½Π΅ΠΉΡ‚Ρ€Π°Π»ΠΈΠ·ΡƒΡŽΡ‰ΠΈΡ… Π°Π½Ρ‚ΠΈΡ‚Π΅Π» ΠΊ SARS-CoV-2. ΠœΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Ρ€Π°Π±ΠΎΡ‚Ρ‹ Π‘Π»ΡƒΠΆΠ±Ρ‹ ΠΊΡ€ΠΎΠ²ΠΈ Π”Π΅ΠΏΠ°Ρ€Ρ‚Π°ΠΌΠ΅Π½Ρ‚Π° здравоохранСния Π³. ΠœΠΎΡΠΊΠ²Ρ‹ (Π”Π—Πœ) ΠΏΠΎ Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠ΅ РП COVID-19. ВсСго Π·Π°Π³ΠΎΡ‚ΠΎΠ²Π»Π΅Π½ΠΎ 1240 Π΄ΠΎΠ·. Нормативная докумСнтация Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π° Ρ€Π°Π±ΠΎΡ‡Π΅ΠΉ Π³Ρ€ΡƒΠΏΠΏΠΎΠΉ Π½Π° основании Π΄Π΅ΠΉΡΡ‚Π²ΡƒΡŽΡ‰Π΅Π³ΠΎ Ρ„Π΅Π΄Π΅Ρ€Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π·Π°ΠΊΠΎΠ½ΠΎΠ΄Π°Ρ‚Π΅Π»ΡŒΡΡ‚Π²Π° ΠΈ ΡƒΡ‚Π²Π΅Ρ€ΠΆΠ΄Π΅Π½Π° Π”Π—Πœ. Как базовая ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ° ΠΎΡ†Π΅Π½ΠΊΠΈ иммунологичСской ΡΠΎΡΡ‚ΠΎΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ РП, ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ Ρ‚ΠΈΡ‚Ρ€ Π²ΠΈΡ€ΡƒΡΠ½Π΅ΠΉΡ‚Ρ€Π°Π»ΠΈΠ·ΡƒΡŽΡ‰ΠΈΡ… Π°Π½Ρ‚ΠΈΡ‚Π΅Π» (ВНА). ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ сопоставлСниС основных характСристик Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ², особСнностСй тСчСния заболСвания, Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² ΠΏΡ€Π΅Π΄Π²Π°Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ тСстирования Π½Π° Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ спСцифичСских Π°Π½Ρ‚ΠΈΡ‚Π΅Π» ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ ИЀА ΠΈ ИΠ₯ЛА с Ρ‚ΠΈΡ‚Ρ€Π°ΠΌΠΈ ВНА Π·Π°Π³ΠΎΡ‚ΠΎΠ²Π»Π΅Π½Π½ΠΎΠΉ РП. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Π Π°Π±ΠΎΡ‚Π° ΠΏΠΎ Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠ΅, обслСдованию, Ρ…Ρ€Π°Π½Π΅Π½ΠΈΡŽ, ΠΎΠ±Π΅ΡΠΏΠ΅Ρ‡Π΅Π½ΠΈΡŽ бСзопасности ΠΈ ΠΏΠ΅Ρ€Π΅Π΄Π°Ρ‡Π΅ Π² мСдицинскиС ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ Π”ΠœΠ— свСТСзамороТСнной ΠΏΠ°Ρ‚ΠΎΠ³Π΅Π½Ρ€Π΅Π΄ΡƒΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΏΠ»Π°Π·ΠΌΡ‹ Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ²-рСконвалСсцСнтов COVID-19 Π±Ρ‹Π»Π° ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΎΠ²Π°Π½Π° Π½Π° основании ΠΏΡ€ΠΈΠΊΠ°Π·Π° Π”Π—Πœ ΠΎΡ‚ 01.04.2020 β„– 325 ΠΊΠ°ΠΊ Π±Π°Π·ΠΎΠ²ΠΎΠ³ΠΎ локального Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Π°. Для ΠΎΠΏΡ‚ΠΈΠΌΠ°Π»ΡŒΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΌΡƒΠ½ΠΈΠΊΠ°Ρ†ΠΈΠΈ с ΡΠΎΡΡ‚ΠΎΡΠ²ΡˆΠΈΠΌΠΈΡΡ Π΄ΠΎΠ½ΠΎΡ€Π°ΠΌΠΈ ΠΈ привлСчСния рСконвалСсцСнтов использовались рСсурсы ΠΊΠΎΠ»Π»-Ρ†Π΅Π½Ρ‚Ρ€Π°. Для эффСктивного ΠΏΡ€Π΅Π΄Π²Π°Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΎΡ‚Π±ΠΎΡ€Π° Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ² ΠΏΡ€ΠΈΠΌΠ΅Π½ΡΠ»ΠΈΡΡŒ Π°Π½Π°Π»ΠΈΠ· характСристик Π΄ΠΎΠ½ΠΎΡ€Π° (ΠΏΠ»Π°Π·ΠΌΠ° с наибольшими значСниями Ρ‚ΠΈΡ‚Ρ€Π° ВНА ΠΎΠΆΠΈΠ΄Π°Π΅ΠΌΠ° ΠΎΡ‚ Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ²-ΠΌΡƒΠΆΡ‡ΠΈΠ½, ΠΏΠ΅Ρ€Π΅Π±ΠΎΠ»Π΅Π²ΡˆΠΈΡ… с ΠΏΡ€ΠΈΠ·Π½Π°ΠΊΠ°ΠΌΠΈ явной вирусной ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠΈ) ΠΈ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ скрининга спСцифичСских Π°Π½Ρ‚ΠΈΡ‚Π΅Π» ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌΠΈ ИЀА ΠΈ ИΠ₯ЛА. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π° систСма обСспСчСния Ρ€Π΅ΠΊΡ€ΡƒΡ‚ΠΈΠ½Π³Π° Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ² ΠΈ процСсса Π·Π°Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ РП для лСчСния Π‘OVID-19, Π²ΠΊΠ»ΡŽΡ‡Π°ΡŽΡ‰Π°Ρ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΡ‹Π΅ Π½ΠΎΡ€ΠΌΠ°Ρ‚ΠΈΠ²Π½Ρ‹Π΅ Π΄ΠΎΠΊΡƒΠΌΠ΅Π½Ρ‚Ρ‹, Π°Π»Π³ΠΎΡ€ΠΈΡ‚ΠΌΡ‹ ΠΎΡ‚Π±ΠΎΡ€Π° ΠΈ привлСчСния Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ², рССстр Π΄ΠΎΠ½ΠΎΡ€ΠΎΠ² ΠΈ Ρ€Π΅Ρ†ΠΈΠΏΠΈΠ΅Π½Ρ‚ΠΎΠ², Π°Π»Π³ΠΎΡ€ΠΈΡ‚ΠΌΡ‹ обСспСчСния эффСктивности ΠΈ бСзопасности РП

    Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma

    No full text
    Background and objectives: COVID-19 convalescent plasma is an experimental treatment against SARS-CoV-2. The aim of this study is to assess the impact of different pathogen reduction methods on the levels and virus neutralizing activity of the specific antibodies against SARS-CoV2 in convalescent plasma. Materials and methods: A total of 140 plasma doses collected by plasmapheresis from COVID-19 convalescent donors were subjected to pathogen reduction by three methods: methylene blue (M)/visible light, riboflavin (R)/UVB and amotosalen (A)/UVA. To conduct a paired comparison, individual plasma doses were divided into 2 samples that were subjected to one of these methods. The titres of SARS-CoV2 neutralizing antibodies (NtAbs) and levels of specific immunoglobulins to RBD, S- and N-proteins of SARS-CoV-2 were measured before and after pathogen reduction. Results: The methods reduced NtAbs titres differently: among units with the initial titre 80 or above, 81% of units remained unchanged and 19% decreased by one step after methylene blue; 60% were unchanged and 40% decreased by one step after amotosalen; after riboflavin 43% were unchanged and 50% (7%, respectively) had a one-step (two-step, respectively) decrease. Paired two-sample comparisons (M vs. A, M vs. R and A vs. R) revealed that the largest statistically significant decrease in quantity and activity of the specific antibodies resulted from the riboflavin treatment. Conclusion: Pathogen reduction with methylene blue or with amotosalen provides the greater likelihood of preserving the immunological properties of the COVID-19 convalescent plasma compared to riboflavin
    corecore